Cartesian Therapeutics Inc (RNAC)

Income Tax Expense

-$9.19M

TTM · Period ending: · USD

RNAC logo

RNAC Income Tax Expense

Latest reported-$9.19M
RNAC TTM Income Tax ($0.00 → -$9.19M)
High-resolution chart · PNG

RNAC income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cartesian Therapeutics Inc Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
-9,193,000
-9,193,000
-9,193,000
287,000
287,000
287,000
287,000
-19,000,000
-19,000,000
-19,000,000
-19,000,000
-288,000
-609,000
-609,000
-609,000
-183,000
15,966,000
15,966,000
15,966,000
15,828,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.